Listed

Presurance Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2026

Filed with the SEC on Aug 12, 2026 and accepted by EDGAR at Aug 12, 2026, 16:00 ET.

Share

Management's discussion and analysis

As filed, 39,512 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For the Periods Ended June 30, 2026 and 2025

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Condensed Consolidated Financial Statements (Unaudited), related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K, filed on March 27, 2026 with the U. S. Securities and Exchange Commission.

Forward-Looking Statements

Certain statements contained in this Quarterly Report on Form 10-Q, which are not statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “seek” and similar terms and phrases, or the negative thereof, may be used to identify forward-looking statements.

The forward-looking statements contained in this report are based on management’s good-faith belief and reasonable judgment based on current information. The forward-looking statements are qualified by important factors, risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those in the forward-looking statements, including those described in our Form 10-K (“Item 1A Risk Factors”) filed with the SEC on March 27, 2026 and included herein, and subsequent reports filed with or furnished to the SEC. Any forward-looking statement made by us in this report speaks only as of the date hereof or as of the date specified herein. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable laws or regulations.

Recent Developments

Reverse Stock Split

On June 1, 2026, the Company effected a 1-for-7 reverse stock split of the Company’s common stock (the "Reverse Stock Split"). As a result of the Reverse Stock Split, every 7 shares of the Company’s common stock issued and outstanding were automatically converted into one new share of common stock. Proportionate adjustments were made to the exercise prices and number of shares of common stock issuable upon exercise of the Company's outstanding stock options and warrants. The Reverse Stock Split did not decrease the number of authorized shares of common stock. No fractional shares were issued in connection with the Reverse Stock Split and any fractional shares resulting from the Reverse Stock Split were rounded down to the nearest whole share. Shareholders who were otherwise entitled to receive fractional shares as a result of the Reverse Stock Split were paid cash in lieu thereof. All shares of the Company’s common stock, per-share data and related information included in the accompanying condensed consolidated financial statements have been retroactively adjusted as though the Reverse Stock Split had been effected prior to all periods presented in accordance with generally accepted accounting principles.

Rights Offering

On February 27, 2026, the Company issued 2,000,000 shares of common stock at a purchase price of $7.00 per share pursuant to a rights offering backstopped by Clarkston Companies, Inc. A portion of the proceeds were used to redeem the $7.5 million of the Company's outstanding Series B Preferred Stock and to contribute $3.0 million to TIC in February 2026. The remaining proceeds are being used for working capital and general corporate purposes.

Redemption of Series B Preferred Stock

The Company redeemed the $7.5 million of Series B Preferred Stock on February 27, 2026.

Business Overview

We are an insurance holding company that markets and services our product offerings through specialty commercial and specialty personal insurance business lines. Currently, we are authorized to write insurance as an excess and surplus lines carrier in 44 states, plus the District of Columbia. We are licensed to write insurance as an admitted carrier in 42 states, plus the District of Columbia. As of June 30, 2026, we offer only homeowners insurance products in Texas, Illinois and Indiana.

Our revenues are primarily derived from premiums earned from our insurance operations. We also generate other revenues through investment income.

Our expenses consist primarily of losses and loss adjustment expenses, agents’ commissions, reinsurance premiums and other underwriting and administrative expenses.

Through our personal insurance lines, we offer homeowners insurance and dwelling fire insurance products to individuals in several states. Our specialty homeowners insurance product line is primarily comprised of low-value dwelling insurance tailored for owners of lower valued homes, which we offer in Texas, Illinois and Indiana. Our commercial lines of business are in runoff.

Critical Accounting Policies and Estimates

In certain circumstances, we are required to make estimates and assumptions that affect amounts reported in our condensed consolidated financial statements and related footnotes. We evaluate these estimates and assumptions periodically on an on-going basis based on a variety of factors. There can be no assurance, however, that actual results will not be materially different than our estimates and assumptions, and that reported results of operations will not be affected by accounting adjustments needed to reflect changes in these estimates and assumptions. During the six months ended June 30, 2026, there were no material changes to our critical accounting policies and estimating methodologies, which are disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Annual Report on Form 10-K filed with the SEC on March 27, 2026.

Executive Overview

The Company's gross written premiums decreased $8.0 million, or 38.0%, to $13.1 million in the second quarter of 2026, compared to $21.1 million for the same period in 2025.

The Company's personal lines gross written premiums decreased $4.8 million, or 26.9%, to $13.1 million in the second quarter of 2026, compared to $17.9 million for the same period in 2025.

The Company reported net income of $2.5 million, or $0.68 per share in the second quarter of 2026, compared to net income of $2.1 million, or $1.17 per share for the same period in 2025. The Company recorded net income of $5.2 million, or $1.66 per share for the six months ended June 30, 2026, compared to net income of $2.6 million, or $1.47 per share for the same period in 2025.

Adjusted operating income, a non-GAAP measure, was $1.3 million, or $0.35 per share during the second quarter of 2026, compared to a $2.1 million loss, or $1.19 per share for the same period in 2025. Adjusted operating income was $384,000, or $0.12 per share for the six months ended June 30, 2026, compared to an adjusted operating loss of $5.8 million, or $3.30 per share for the same period in 2025.

Our underwriting combined ratio was 69.5% and 121.1% for the three months ended June 30, 2026 and 2025, respectively. Our underwriting combined ratio was 86.4% and 131.2% for the six months ended June 30, 2026 and 2025, respectively.

Results of Operations for the Three Months Ended June 30, 2026 and 2025

The following table summarizes our operating results for the periods indicated (dollars in thousands):

Summary of Operating Results

Three Months Ended June 30, 2026 2025 $ Change % Change
Gross written premiums $13,070 $21,079 $(8,009) (38.0%)
Net written premiums $16,652 $1,383 $15,269 *
Net earned premiums $6,808 $9,564 $(2,756) (28.8)%
Losses and loss adjustment expenses, net 1,672 6,564 (4,892) (74.5)%
Policy acquisition costs 1,926 2,287 (361) (15.8)%
Segment operating expenses 1,134 2,711 (1,577) (58.2)%
Underwriting gain (loss) 2,076 (1,998) 4,074 *
Other corporate expenses 1,197 1,657 (460) (27.8)%
Net investment income 1,040 1,298 (258) (19.9)%
Net realized investment gains (losses) (87) (28) (59) *
Change in fair value of equity securities 81 (65) 146 *
Change in fair value of contingent considerations 1,220 5,355 (4,135) (77.2)%
Other income 80 10 70 *
Interest expense 677 864 (187) (21.6)%
Income (loss) before income taxes 2,536 2,051 485 23.6%
Income tax expense (benefit) — — — *
Net income (loss) $2,536 $2,051 $485 23.6%
Book value per common share outstanding $7.41 $16.15
Underwriting Ratios:
Loss ratio (1) 24.6% 68.8%
Expense ratio (2) 44.9% 52.3%
Combined ratio (3) 69.5% 121.1%

(1) The loss ratio is the ratio, expressed as a percentage, of net losses and loss adjustment expenses to net earned premiums.

(2) The expense ratio is the ratio, expressed as a percentage, of policy acquisition costs and segment operating expenses to net earned premiums.

(3) The combined ratio is the sum of the loss ratio and the expense ratio. A combined ratio under 100% indicates an underwriting profit. A combined ratio over 100% indicates an underwriting loss.

* Percentage change is not meaningful.

Premiums

Premiums are earned ratably over the term of the policy, whereas written premiums are reflected on the effective date of the policy. Almost all commercial lines and homeowners products have annual policies, under which premiums are earned evenly over one year. The resulting net earned premiums are impacted by the gross and ceded written premiums, earned ratably over the terms of the policies.

Our premiums are presented below for the three months ended June 30, 2026 and 2025 (dollars in thousands):

Summary of Premium Revenue

Gross written premiums Three Months Ended June 30, 2026 2025 $ Change % Change
Personal lines $13,073 $17,889 $(4,816) (26.9)%
Commercial lines (3) 3,190 (3,193) *
Total $13,070 $21,079 $(8,009) (38.0)%
Net written premiums
Personal lines $16,632 $1,816 $14,816 *
Commercial lines 20 (433) 453 *
Total $16,652 $1,383 $15,269 *
Net earned premiums
Personal lines $6,703 $9,096 $(2,393) (26.3)%
Commercial lines 105 468 (363) (77.6)%
Total $6,808 $9,564 $(2,756) (28.8)%

* Percentage change is not meaningful.

Gross written premiums decreased $8.0 million, or 38.0%, to $13.1 million for the three months ended June 30, 2026, compared to $21.1 million for the same period in 2025.

Personal lines gross written premiums decreased $4.8 million, or 26.9%, to $13.1 million in the second quarter of 2026, compared to $17.9 million for the same period in 2025. The decrease was due to underwriting changes that affected volume. Our main focus remains on prudent, steady growth in Texas.

Commercial lines gross written premiums were essentially zero in the second quarter of 2026, compared to $3.2 million for the same period in 2025. The Company's commercial lines of business are in runoff. The Company does not expect to write any commercial lines business in the near term.

Net written premiums increased $15.3 million, to $16.7 million in the second quarter of 2026, compared to $1.4 million for the same period in 2025. The increase in net written premiums during the quarter was primarily due to the termination of the Company's quota share reinsurance agreement that ceded 50% of premiums on substantially all of its homeowners business on May 31, 2026. The termination of the agreement generated a negative $9.3 million of ceded written premiums in the second quarter of 2026. The quota share agreement that was entered into on June 1, 2025 resulted in $13.7 million of additional ceded written premiums in the second quarter of 2025, significantly reducing net written premiums. All homeowners unearned premiums were ceded under the quota share agreement on June 1, 2025. All ceded unearned premiums under the quota share agreement were reversed as of May 31, 2026.

Net earned premiums decreased $2.8 million, or 28.8%, to $6.8 million during the second quarter of 2026, compared to $9.6 million for the same period in 2025. This decrease was primarily related to the decrease in gross written premiums during the quarter.

Losses and Loss Adjustment Expenses

The tables below detail our losses and loss adjustment expenses and loss ratios in our underwriting business for the three months ended June 30, 2026 and 2025 (dollars in thousands):

Three months ended June 30, 2026 Personal Lines Commercial Lines Total
Accident year net losses and LAE $3,734 $48 $3,782
Net (favorable) adverse development 299 (2,409) (2,110)
Calendar year net losses and LAE $4,033 $(2,361) $1,672
Accident year loss ratio 55.7% * 55.6%
Net (favorable) adverse development 4.5% * (31.0)%
Calendar year loss ratio 60.2% * 24.6%
Three months ended June 30, 2025 Personal Lines Commercial Lines Total
Accident year net losses and LAE $5,128 $887 $6,015
Net (favorable) adverse development 424 125 549
Calendar year net losses and LAE $5,552 $1,012 $6,564
Accident year loss ratio 56.5% 189.7% 63.0%
Net (favorable) adverse development 4.7% 26.7% 5.8%
Calendar year loss ratio 61.2% 216.4% 68.8%

* Percentage change is not meaningful.

Net losses and LAE decreased by $4.9 million, or 74.5%, to $1.7 million during the second quarter of 2026, compared to $6.6 million for the same period in 2025. The decrease was partially due to a reduction in net earned premiums as the commercial lines of business are in runoff and we focus on the specialty homeowners business. The Company also experienced $2.4 million of favorable development related to its legacy commercial lines business in the second quarter of 2026.

Expense Ratio

Our expense ratio is a measure of the efficiency and performance of the commercial and personal lines of business (our risk-bearing underwriting operations). It is calculated by dividing the sum of policy acquisition costs and other underwriting expenses by net earned premiums. Costs that cannot be readily identifiable as a direct cost of a segment or product line remain in Corporate for segment reporting purposes. The expense ratio excludes Corporate expenses. Due to the commercial lines of business being in runoff, the expense ratios for commercial lines are not deemed to be meaningful.

The table below provides the expense ratio by major component.

Personal Lines Three Months Ended June 30, 2026 2025
Policy acquisition costs 28.5% 28.6%
Operating expenses 6.7% 24.4%
Total 35.2% 53.0%
Commercial Lines
Policy acquisition costs * (66.1)%
Operating expenses * 107.0%
Total * 40.9%
Total Underwriting
Policy acquisition costs 28.3% 23.9%
Operating expenses 16.6% 28.4%
Total 44.9% 52.3%

30

* Percentage change is not meaningful.

Our expense ratio decreased by 7.4% in the second quarter of 2026, to 44.9%, compared to 52.3% for the same period in 2025.

Policy acquisition costs are costs we incur to issue policies, which include commissions, premium taxes and underwriting reports. The Company offsets direct commissions with ceding commissions from reinsurers. The percentage of policy acquisition costs to net earned premiums increased by 4.4% during the second quarter of 2026 to 28.3%, compared to 23.9% during the same period in 2025, due to the removal of the quota share reinsurance agreement effective May 31, 2026, which had provided for more ceding commission in the second quarter of 2025 than the same period in 2026.

Operating expenses consist primarily of employee compensation, information technology and occupancy costs, such as rent and utilities. Operating expenses as a percent of net earned premiums decreased by 11.8% during the second quarter of 2026 to 16.6%, compared to 28.4% for the same period in 2025. The decrease in the ratio was mostly due to improved administrative cost efficiency.

Segment Results

We measure the performance of our consolidated results, in part, based on our underwriting gain or loss. The following table provides the underwriting gain or loss for the three months ended June 30, 2026 and 2025 (dollars in thousands):

Segment Gain (Loss)

Three Months Ended June 30, 2026 2025 $ Change
Personal Lines $312 $(1,263) $1,575
Commercial Lines 1,764 (735) 2,499
Total underwriting gain (loss) $2,076 $(1,998) $4,074

Other Corporate Expenses

Other corporate expenses consist of expenses not allocated to segments. These expenses include public company costs, as well as other expenses such as legal and consulting expenses not directly relating to the insurance operations and expense related to the funds-withheld obligation. Other corporate expenses decreased by $460,000, or 27.8%, to $1.2 million for the three months ended June 30, 2026, compared to $1.7 million for the same period in 2025. The decrease in other corporate expenses was largely due to costs associated with the CIS earnout that were incurred in 2025 that were not incurred in 2026.

Results of Operations for the Six Months Ended June 30, 2026 and 2025

The following table summarizes our operating results for the periods indicated (dollars in thousands):

Summary of Operating Results

Six months ended June 30, 2026 2025 $ Change % Change
Gross written premiums $24,539 $37,252 $(12,713) (34.1)%
Net written premiums $22,727 $12,223 $10,504 85.9%
Net earned premiums $12,733 $19,879 $(7,146) (35.9)%
Losses and loss adjustment expenses, net 5,001 15,838 (10,837) (68.4)%
Policy acquisition costs 3,484 4,964 (1,480) (29.8)%
Segment operating expenses 2,511 5,287 (2,776) (52.5)%
Underwriting gain (loss) 1,737 (6,210) 7,947 *
Other corporate expenses 1,920 1,942 (22) 1.1%
Net investment income 2,150 2,587 (437) (16.9)%
Net realized investment gains (losses) (101) (25) (76) *
Change in fair value of equity securities 111 (257) 368 *
Change in fair value of contingent considerations 5,710 9,750 (4,040) (41.4)%
Other income 86 75 11 14.7%
Interest expense 2,653 1,405 1,248 88.8%
Income (loss) before income taxes 5,120 2,573 2,547 99.0%
Income tax expense (benefit) (38) — (38) *
Net income (loss) $5,158 $2,573 $2,585 100.5%
Book value per common share outstanding $7.41 $16.15
Underwriting Ratios:
Loss ratio (1) 39.3% 79.7%
Expense ratio (2) 47.1% 51.5%
Combined ratio (3) 86.4% 131.2%

(1) The loss ratio is the ratio, expressed as a percentage, of net losses and loss adjustment expenses to net earned premiums.

(2) The expense ratio is the ratio, expressed as a percentage, of policy acquisition costs and segment operating expenses to net earned premiums.

(3) The combined ratio is the sum of the loss ratio and the expense ratio. A combined ratio under 100% indicates an underwriting profit. A combined ratio over 100% indicates an underwriting loss.

* Percentage change is not meaningful.

Premiums

Premiums are earned ratably over the term of the policy, whereas written premiums are reflected on the effective date of the policy. Almost all commercial lines and homeowners products have annual policies, under which premiums are earned evenly over one year. The resulting net earned premiums are impacted by the gross and ceded written premiums, earned ratably over the terms of the policies.

Our premiums are presented below for the six months ended June 30, 2026 and 2025 (dollars in thousands):

Summary of Premium Revenue

Gross written premiums Six months ended June 30, 2026 2025 $ Change % Change
Personal lines $24,560 $32,015 $(7,455) (23.3)%
Commercial lines (21) 5,237 (5,258) *
Total $24,539 $37,252 $(12,713) (34.1)%
Net written premiums
Personal lines $22,723 $14,259 $8,464 59.4%
Commercial lines 4 (2,036) 2,040 *
Total $22,727 $12,223 $10,504 85.9%
Net earned premiums
Personal lines $12,495 $18,080 $(5,585) (30.9)%
Commercial lines 238 1,799 (1,561) (86.8)%
Total $12,733 $19,879 $(7,146) (35.9)%

* Percentage change is not meaningful.

Gross written premiums decreased $12.7 million, or 34.1%, to $24.5 million for the six months ended June 30, 2026, compared to $37.3 million for the same period in 2025.

Personal lines gross written premiums decreased $7.5 million, or 23.3%, to $24.6 million for the six months ended June 30, 2026, compared to $32.0 million for the same period in 2025. The decrease was due to underwriting changes that affected volume. Our main focus remains on prudent, steady growth in Texas.

Commercial lines gross written premiums were essentially zero for the six months ended June 30, 2026, compared to $5.2 million for the same period in 2025. The Company's commercial lines of business are in runoff. The Company does not expect to write any commercial lines business in the near term.

Net written premiums increased $10.5 million, or 85.9%, to $22.7 million for the six months ended June 30, 2026, compared to $12.2 million for the same period in 2025. The increase in net written premiums during the quarter was primarily due to the termination of the Company's quota share reinsurance agreement that ceded 50% of premiums on substantially all of its homeowners business on May 31, 2026. The termination of the agreement generated a negative $9.3 million of ceded written premiums for the six months ended June 30, 2026. The quota share agreement that was entered into on June 1, 2025 resulted in $13.7 million of additional ceded written premiums for the six months ended June 30, 2025, significantly reducing net written premiums. All homeowners unearned premiums were ceded under the quota share agreement on June 1, 2025. All ceded unearned premiums under the quota share agreement were reversed as of May 31, 2026.

Net earned premiums decreased $7.1 million, or 35.9%, to $12.7 million for the six months ended June 30, 2026, compared to $19.9 million for the same period in 2025. This decrease was primarily related to the decrease in gross written premiums during the quarter.

Losses and Loss Adjustment Expenses

The tables below detail our losses and loss adjustment expenses and loss ratios in our underwriting business for the six months ended June 30, 2026 and 2025 (dollars in thousands):

Six months ended June 30, 2026 Personal Lines Commercial Lines Total
Accident year net losses and LAE $7,216 $74 $7,290
Net (favorable) adverse development 417 (2,706) (2,289)
Calendar year net losses and LAE $7,633 $(2,632) $5,001
Accident year loss ratio 57.8% * 57.2%
Net (favorable) adverse development 3.3% * (17.9)%
Calendar year loss ratio 61.1% * 39.3%
Six months ended June 30, 2025 Personal Lines Commercial Lines Total
Accident year net losses and LAE $12,133 $3,012 $15,145
Net (favorable) adverse development 1,188 (495) 693
Calendar year net losses and LAE $13,321 $2,517 $15,838
Accident year loss ratio 67.1% 167.5% 76.2%
Net (favorable) adverse development 6.6% (27.5)% 3.5%
Calendar year loss ratio 73.7% 140.0% 79.7%

* Percentage change is not meaningful.

Net losses and LAE decreased by $10.8 million, or 68.4%, to $5.0 million for the six months ended June 30, 2026, compared to $15.8 million for the same period in 2025. The decrease was mostly due to a significant reduction in net earned premiums as the commercial lines of business are in runoff and we focus on the specialty homeowners business. The Company also experienced $2.7 million of favorable development related to its legacy commercial lines business for the six months ended June 30, 2026.

Expense Ratio

Our expense ratio is a measure of the efficiency and performance of the commercial and personal lines of business (our risk-bearing underwriting operations). It is calculated by dividing the sum of policy acquisition costs and other underwriting expenses by net earned premiums. Costs that cannot be readily identifiable as a direct cost of a segment or product line remain in Corporate for segment reporting purposes. The expense ratio excludes Corporate expenses. Due to the commercial lines of business being in runoff, the expense ratios for commercial lines are not deemed to be meaningful.

The table below provides the expense ratio by major component.

Personal Lines Six months ended June 30, 2026 2025
Policy acquisition costs 27.8% 29.4%
Operating expenses 7.6% 24.4%
Total 35.4% 53.8%
Commercial Lines
Policy acquisition costs * (19.7)%
Operating expenses * 49.2%
Total * 29.5%
Total Underwriting
Policy acquisition costs 27.4% 24.9%
Operating expenses 19.7% 26.6%
Total 47.1% 51.5%

* Percentage change is not meaningful.

Our expense ratio decreased by 4.4% for the six months ended June 30, 2026, to 47.1%, compared to 51.5% for the same period in 2025.

Policy acquisition costs are costs we incur to issue policies, which include commissions, premium taxes and underwriting reports. The Company offsets direct commissions with ceding commissions from reinsurers. The percentage of policy acquisition costs to net earned premiums increased by 2.5% for the six months ended June 30, 2026, to 27.4%, compared to 24.9% during the same period in 2025, due to the removal of the quota share reinsurance agreement effective May 31, 2026, which had provided for more ceding commission in the second quarter of 2025 than the same period in 2026.

Operating expenses consist primarily of employee compensation, information technology and occupancy costs, such as rent and utilities. Operating expenses as a percent of net earned premiums decreased by 6.9% for the six months ended June 30, 2026, to 19.7%, compared to 26.6% for the same period in 2025. The decrease in the ratio was mostly due to improved administrative cost efficiency.

Segment Results

We measure the performance of our consolidated results, in part, based on our underwriting gain or loss. The following table provides the underwriting gain or loss for the six months ended June 30, 2026 and 2025 (dollars in thousands):

Segment Gain (Loss)

Six months ended June 30, 2026 2025 $ Change
Personal Lines $434 $(4,961) $5,395
Commercial Lines 1,303 (1,249) 2,552
Total underwriting gain (loss) $1,737 $(6,210) $7,947

Other Corporate Expenses

Other corporate expenses consist of expenses not allocated to segments. These expenses include public company costs, as well as other expenses such as legal and consulting expenses not directly relating to the insurance operations and expense related to the funds-withheld obligation. Other corporate expenses remained flat at $1.9 million for the six months ended June 30, 2026 and 2025.

Liquidity and Capital Resources

Sources and Uses of Funds

At June 30, 2026, the Company had $41.2 million in cash, cash equivalents and short-term investments. Our principal sources of funds are insurance premiums, investment income and proceeds from maturities and sales of invested assets. These funds are primarily used to pay claims, commissions, employee compensation, taxes and other operating expenses, and service debt and mandatorily redeemable preferred stock.

We conduct our business operations primarily through our Insurance Company Subsidiaries. The Parent Company's ability to service debt and mandatorily redeemable preferred stock and pay administrative expenses is primarily reliant upon our intercompany service fees paid by the Insurance Company Subsidiaries to the Parent Company for management, administrative, and information technology services provided to the Insurance Company Subsidiaries by the Parent Company. Secondarily, the Parent Company may receive dividends from the Insurance Company Subsidiaries; however, this is not the primary means by which the Parent Company supports its funding as state insurance laws restrict the ability of our Insurance Company Subsidiaries to declare dividends to the Parent Company. Generally, the limitations are based on the greater of statutory net income for the preceding year or 10% of statutory surplus at the end of the preceding year. There were no dividends paid from our Insurance Company Subsidiaries for the six months ended June 30, 2026 and 2025. We do not anticipate any dividends being paid to the Parent Company from our insurance subsidiaries in the near term.

Due to significant losses in 2025, much of which is attributable to the legacy commercial liability lines of business (which are now all in runoff), both Insurance Company Subsidiaries lacked sufficient capital to continue to underwrite the volume of business they have historically written. Accordingly, PHI contributed $17.5 million into TIC during 2025 and the first quarter of 2026. In addition, PHI contributed all of its $7.6 million ownership interest in WPIC to TIC effective December 31, 2025. Even with these contributions, TIC fell within the Company Action Level of the Risk Based Capital ("RBC") with an RBC ratio of 236% as of December 31, 2025, and was required to submit an updated plan of remediation to its domiciliary regulator. TIC is also subject to additional regulatory monitoring requirements as a result of the Company not being above the minimum required RBC levels as of December 31, 2025.

To fund these additional contributions, PHI raised $7.5 million from the issuance of the Series B Preferred Stock in the first quarter of 2025, utilized proceeds from the second $10.0 million earnout from the CIS Sale, which were received in the second quarter of 2025, and raised $8.0 million from the issuance of the Series C Preferred Stock in December 2025. In February 2026, PHI completed a backstopped rights offering for $14.0 million utilizing a portion of the proceeds to redeem the $7.5 million Series B Preferred Stock and contribute $3.0 million of cash to TIC in February 2026. WPIC no longer writes any business and TIC’s writings are significantly constrained by its diminished capital position.

As an effort to support TIC and WPIC, PHI received no intercompany service fees from the Insurance Company Subsidiaries during 2025 and only $800,000 and $1.3 million for the three and six months ended June 30, 2026, respectively. PHI has relied significantly on proceeds from sales of assets and capital raises over the last two years in order to ensure its ability to meet its obligations as they became due.

With future anticipated revenue from TIC and the receipt of the fully earned $10.0 million third earnout payment by August 31, 2026, management believes the Company has the ability to meet its obligations as they become due over the next twelve months.

Cash Flows

Operating Activities. Cash used in operating activities for the six months ended June 30, 2026 was $20.2 million, compared to $18.0 million for the same period in 2025. The $2.2 million increase in cash used in operating activities was primarily due to a $5.7 million decrease in net premiums collected during the first six months of 2026, compared to the same period in 2025. In addition, there was a $467,000 increase in interest paid during the first six months of 2026, compared to the same period in 2025. These were offset by a decrease of $10.5 million of net losses paid during the first six months of 2026, compared to the same period in 2025.

Investing Activities. Cash used in investing activities for the six months ended June 30, 2026 was $613,000, compared to $4.8 million of cash provided by investing activities for the same period in 2025. The $5.4 million increase in cash used by investing activities was primarily due to the Company not receiving any proceeds from the third contingent consideration from the CIS Sale for the six months ended June 30, 2026, compared to the Company receiving $10.0 million from the second contingent consideration from the CIS Sale for the same period in 2025.

Financing Activities. Cash provided by financing activities for the six months ended June 30, 2026 was $6.2 million compared to $7.5 million for the same period in 2025. The $1.3 million decrease in cash provided by financing activities was attributed to the $7.5 million repayment of the Series B Preferred Stock during the six months of 2026. This was offset by $14.0 million of common stock issued during the first six months of 2026. The Company also paid $261,000 related to common stock issuance costs during the six months of 2026.

Statutory Capital and Surplus

Our Insurance Company Subsidiaries are required to file quarterly and annual financial reports with state insurance regulators. These financial reports are prepared using statutory accounting practices promulgated by the Insurance Company Subsidiaries’ state of domiciliary, rather than GAAP. The Insurance Company Subsidiaries’ aggregate statutory capital and surplus, which is a statutory measure of equity, was $42.7 million and $42.6 million at June 30, 2026 and December 31, 2025, respectively.

Non-GAAP Financial Measures

Adjusted Operating Income and Adjusted Operating Income Per Share

Adjusted operating income or loss and adjusted operating income or loss per share are non-GAAP measures that represent net income or loss excluding net realized investment gains (losses), change in fair value of equity securities, change in fair value of contingent considerations, contingent consideration bonus expense and additional accretion of warrants from Series B Preferred Stock payoff. The most directly comparable financial GAAP measures to adjusted operating income and adjusted operating income per share are net income allocable to common shareholders and net income allocable to common shareholders per share, respectively. Adjusted operating income and adjusted operating income per share are intended as supplemental information and are not meant to replace net income allocable to common shareholders or net income allocable to common shareholders per share. Adjusted operating income and adjusted operating income per share should be read in conjunction with the GAAP financial results. Our definition of adjusted operating income may be different from that used by other companies. The following is a reconciliation of net income (loss) to adjusted operating income (loss) (dollars in thousands), as well as net income (loss) allocable to common shareholders per share to adjusted operating income (loss) per share:

Three Months Ended June 30, 2026 2025 Six months ended June 30, 2026 2025
Net income (loss) $2,536 $2,051 $5,158 $2,573
Less:
Net realized investment gains (losses) (87) (28) (101) (25)
Change in fair value of equity securities 81 (65) 111 (257)
Change in fair value of contingent considerations 1,220 5,355 5,710 9,750
Contingent consideration bonus expense * — (1,141) — (1,141)
Additional accretion of warrants from Series B Preferred Stock payoff — — (946) —
Impact of income tax expense (benefit) from adjustments ** — — — —
Adjusted operating income (loss) $1,322 $(2,070) $384 $(5,754)
Weighted average common shares diluted 3,746,114 1,746,125 3,105,236 1,746,125
Diluted income (loss) per common share:
Net income (loss) $0.68 $1.17 $1.66 $1.47
Less:
Net realized investment gains (losses) (0.02) (0.02) (0.03) (0.01)
Change in fair value of equity securities 0.02 (0.04) 0.04 (0.15)
Change in fair value of contingent considerations 0.33 3.07 1.84 5.58
Contingent consideration bonus expense * — (0.65) — (0.65)
Additional accretion of warrants from Series B Preferred Stock payoff — — (0.31) —
Impact of income tax expense (benefit) from adjustments ** — — — —
Adjusted operating income (loss) per share $0.35 $(1.19) $0.12 $(3.30)

* See Note 13 ~ Commitments and Contingencies for further information about the contingent consideration bonus expense.

** The Company has recorded a full valuation allowance against its deferred tax assets as of June 30, 2026 and June 30, 2025, respectively. As a result, there were no taxable impacts to adjusted operating income (loss) from the adjustments to net income (loss) in the table above after taking into account the use of net operating losses and the change in the valuation allowance.

We use adjusted operating income or loss and adjusted operating income or loss per share to assess our performance and to evaluate the results of our overall business. We believe these measures provide investors with valuable information relating to our ongoing performance that may be obscured by the net effect of realized gains and losses as a result of our market risk sensitive instruments, which primarily relate to debt securities that are available for sale and not held for trading purposes. The change in fair value of equity securities and realized gains and losses may vary significantly between periods and are generally driven by external economic developments, such as capital market conditions. Accordingly, adjusted operating income excludes the effect of items that tend to be highly variable from period to period and highlights the results from our ongoing business operations and the underlying results of our business. We believe that it is useful for investors to evaluate adjusted operating income and adjusted operating income per share, along with net income and net income per share, when reviewing and evaluating our performance.

Recent Accounting Pronouncements

Refer to Note 1 ~ Summary of Significant Accounting Policies – Accounting Guidance Not Yet Adopted of the Notes to the Condensed Consolidated Financial Statements for detailed information regarding recently issued accounting pronouncements.

Controls and procedures

As filed, 1,301 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Company’s management, including its Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") as of June 30, 2026. Based on such evaluations, the Company's Chief Executive Officer and Chief Financial Officer have concluded the Company’s disclosure controls and procedures are effective in recording, processing, summarizing, and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, and that information is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

For the three months ended June 30, 2026, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that have materially affected, or are reasonably likely to materially affect the Company's internal control over financial reporting.

Risk factors

As filed, 157 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes to the risk factors disclosed in our Annual Report on Form 10-K (“Item 1A Risk Factors”) filed with the SEC on March 27, 2026.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2026-04-01 to 2026-06-30$9.1mus-gaap:Revenues
Revenue6 months2026-01-01 to 2026-06-30$20.7mus-gaap:Revenues
Operating income3 months2026-04-01 to 2026-06-30$2.1mus-gaap:OperatingIncomeLoss
Operating income6 months2026-01-01 to 2026-06-30$1.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2026-04-01 to 2026-06-30$677.0kus-gaap:InterestExpense
Interest expense6 months2026-01-01 to 2026-06-30$2.7mus-gaap:InterestExpense
Income tax3 months2026-04-01 to 2026-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2026-01-01 to 2026-06-30−$38.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2026-04-01 to 2026-06-30$2.5mus-gaap:ProfitLoss
Net income6 months2026-01-01 to 2026-06-30$5.2mus-gaap:ProfitLoss
Diluted EPS3 months2026-04-01 to 2026-06-30$0.68us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2026-01-01 to 2026-06-30$1.66us-gaap:EarningsPerShareDiluted
Basic EPS3 months2026-04-01 to 2026-06-30$0.68us-gaap:EarningsPerShareBasic
Basic EPS6 months2026-01-01 to 2026-06-30$1.66us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2026-04-01 to 2026-06-303,746,114 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2026-01-01 to 2026-06-303,105,236 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2026-01-01 to 2026-06-30−$20.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2026-06-30$12.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2026-06-30$222.5mus-gaap:Assets
Total liabilitiesAt period end2026-06-30$194.7mus-gaap:Liabilities
Long-term debtAt period end2026-06-30$12.3mus-gaap:LongTermDebt
Shareholders' equityAt period end2026-06-30$27.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-26-346778. Last ingested by Listed: Nov 12, 2026, 23:54 ET. Listed shows no prices and gives no investment advice.